Search Results 91-100 of 17287 for egfr
CKD-EPI eGFR ≥20 to <45 mL/min/1.73m² or ... Diabetes mellitus type 2 and prior atherosclerotic cardiovascular disease with an eGFR >60 mL/min/1.73m².
EGFR promotes cancer growth. Cetuximab (Erbitux) and panitumumab (Vectibix) target EGFR. These medicines are used to treat people with genetic changes known as ...
... EGFR antibody therapy) that are used in routine clinical practice. Currently, the only way to know if your tumor has one of these mutations is to take a ...
At present, we are enrolling participants with CKD, with a subset of participants with diabetic kidney disease (DKD), aged 40-80 years, and eGFR 15-60 mL/min/ ...
... (EGFR – epidermal growth factor receptor). Um terceiro participante genético ... EGFR", diz Howard Crawford. "O ponto principal é o de que, sem o EGFR ...
Additional patients limited to those with EGFR mutations may be enrolled following the initial study period as needed to ensure adequate sample sizes needed to ...
... (EGFR) activating mutations. This study will also assess overall survival, overall response rate, progression free survival assessed by the investigator ...
Studies of CI1033, an EGFR tyrosine kinase inhibitor, combined with topoisomerase I inhibitors revealed a novel mechanism of action for CI1033. Dr. Erlichman ...
Combination of Lurbinectedin and Osimertinib for Treatment of EGFR-Mutated Transformed SCLC: A Brief Report. JTO Clin Res Rep. 2025 Jun; 6 (6):100807 Epub ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!